Medical Marijuana, Inc. Launches Pharma Subsidiary in Brazil; Expands Access to CBD Products in Pharmacies4 min read
San Diego, CA – (NewMediaWire) – May perhaps 26, 2022 – Health-related Marijuana, Inc. (OTC: MJNA) (the “Company”), the 1st-at any time publicly traded cannabis company in the United States that released the world’s initial-at any time hashish-derived nutraceutical goods, brand names, and source chain, introduced now that it has introduced its to start with pharmaceutical subsidiary, HM Pharma, in Brazil.
“We have been operating really hard to hook up and create significant associations with professional medical specialists and people in Brazil. This new product sales channel will open up new avenues for continued development by bringing our cannabidiol (CBD) merchandise to pharmacies all through the country,” claimed Matheus Patelli, Managing Director of HM Pharma. “Not only will our products be far more reasonably priced than other CBD products and solutions bought at drugstores in Brazil, but they will be of the optimum high-quality.”
In Brazil, CBD is at the moment permitted only for health care use with authorization from the country’s Nationwide Sanitary Surveillance Agency (Anvisa). HM Pharma will work below Anvisa Normative 327/2019 which will allow the firm to promote its products and solutions in pharmacies. Buyers will soon have the decision to acquire HM Pharma in a pharmacy at the level of sale with a doctor’s prescription or proceed to purchase from HempMeds® Brasil making use of Brazil’s Compassionate Use regulation. The business expects that HM Pharma items will be on pharmacy shelves by the conclusion of 2022.
Medical Marijuana, Inc. subsidiary HempMeds® Brasil was the initially organization to lawfully import products to Brazil in 2015 making use of Brazil’s Compassionate Use regulations. The compassionate use marketplace in Brazil is thriving and it will go on to coexist with the professional medical sector. HempMeds® Brasil, which is now growing at 75.8% a lot quicker than the total Brazilian CBD marketplace and is a single of the biggest players in Brazil’s cannabis market, will proceed to operate underneath the compassionate use model, whilst HM Pharma will operate beneath Anvisa Normative 327/2019.
“HempMeds Brazil has imported above 150 thousand prescription items to Brazil by the compassionate design considering that 2015, and we continue to mature at an typical level of 50% yearly. Our marketplace leadership reflects the high-quality of our solutions, buyer care and doctor associations,” included Patelli.
“Brazil has led the way with respect to Medical Marijuana, Inc.’s Latin American growth. We are confident that this will keep on with our entrance into the pharmaceutical room,” reported Health-related Marijuana, Inc. CEO Blake Schroeder. “HM Pharma has good prospective to increase important price for our shareholders and will enable larger totally free accessibility to hashish-based medicine to individuals in Brazil than at any time before”.
About Medical Marijuana, Inc.
We are a enterprise of firsts®. Healthcare Marijuana, Inc. (MJNA) is a hashish company with 3 distinct business enterprise units in the non-psychoactive cannabinoid room: a world-wide portfolio of cannabinoid-dependent nutraceutical brands led by Kannaway® and HempMeds® a pioneer in sourcing the highest-excellent legal non-psychoactive hashish solutions derived from industrial hemp and a cannabinoid-primarily based scientific study and botanical drug enhancement sector led by its pharmaceutical expense providers and associates like AXIM® Biotechnologies, Inc. and Neuropathix. Health-related Marijuana, Inc. was named a best CBD producer by CNBC. Medical Marijuana, Inc. was also the very first organization to acquire historic import permits for CBD products from the governments of Brazil, Mexico, Argentina, and Paraguay and is a leader in the enhancement of international marketplaces. The firm’s flagship solution Actual Scientific Hemp Oil has been used in many profitable medical experiments in the course of Mexico and Brazil to realize its security and efficacy.
Professional medical Cannabis, Inc.’s headquarters is in San Diego, California, and further details is readily available at OTCMarkets.com or by viewing www.medicalmarijuanainc.com. To see Clinical Marijuana, Inc.’s company movie, simply click here.
This push release may well incorporate particular ahead-wanting statements and info, as outlined inside of the that means of Section 27A of the Securities Act of 1933 and Segment 21E of the Securities Exchange Act of 1934, and is subject matter to the Secure Harbor developed by these sections. This content is made up of statements about expected long run events and/or money outcomes that are ahead-wanting in nature and topic to hazards and uncertainties. These kinds of ahead-seeking statements by definition entail threats, uncertainties and other variables, which may well induce the precise success, performance or achievements of Professional medical Marijuana, Inc. to be materially different from the statements produced herein.
Food AND DRUG ADMINISTRATION (Fda) DISCLOSURE
These statements have not been evaluated by the Food stuff and Drug Administration. This products is not meant to diagnose, treat, treatment, or avoid any disorder.
Professional medical Cannabis, Inc. does not promote or distribute any merchandise that are in violation of the United States Controlled Substances Act.
Get hold of:
Community Relations Contact:
Trader Relations Make contact with:
P. (858) 283-4016